A new comprehensive analysis of thyroid cancer from The Cancer Genome Atlas Research Network has identified markers of aggressive tumors, which could allow for better targeting of appropriate treatments to individual patients.
Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. The burden was greatest among patients who received chemotherapy.
From the University of Michigan Comprehensive Cancer Center, head and neck surgeon Carol R. Bradford, M.D., chair of otolaryngology-head and neck surgery, was elected to the Institute of Medicine in recognition of her major contributions to the advancement of the medical sciences, health care and public health.
Where patients live in the country may determine whether they receive minimally invasive colon cancer surgery, a new study from U-M Comprehensive Cancer Center researchers finds.
The majority of patients diagnosed with sarcoma will be cured of their disease and live cancer-free. But as they age, these patients are at risk of developing another medical condition related to their sarcoma treatment.A new clinic opening this week at the University of Michigan aims to help adults who were treated for sarcoma, a cancer of the bone and connective tissue.
University of Michigan surgical oncologist Lisa Newman was interviewed Wednesday on the Today Show’s official kickoff of the #PinkPower” series for National Breast Cancer Awareness month. Donning pink along with the rest of the crowd at the Rockefeller Center plaza in Manhattan and aside former Good Morning America host and breast cancer survivor Joan Lunden, Newman discussed advances in research and treatment.
The 2014-15 Cancer Center Flu Vaccine Clinic is open on level B1 and appointments can be scheduled during your clinic visit for Monday through Friday, 8:00 a.m. – 6:00 p.m. Walk-in appointments take place after 6 p.m. at level B1 Reception area A.
Researchers at the University of Michigan School of Nursing and Comprehensive Cancer Center have received a $2.3 million grant to study oncology nurses’ exposure to hazardous drugs, including identifying ways to reduce exposure. According to Christopher Friese, Ph.D., R.N., AOCN, FAAN, University of Michigan School of Nursing assistant professor and member of U-M’s Comprehensive Cancer Center and Institute for Healthcare Policy and Innovation, there are significant acute and long-term side effects from hazardous drug exposures in oncology settings, but not enough evidence-based, risk-reduction efforts to protect health care workers.
Gene therapy developed by Dr. Maria Castro and Dr. Pedro Lowenstein will now get the first test in human patients. The experimental approach, based on their research while at the University of Michigan, delivers two different genes directly into the brains of patients following the operation to remove the bulk of their tumors.
QVC and FFANY presented a check for $342,143 to the Cancer Center's Breast Oncology Program, one of nine beneficiaries of the 2013 QVC Presents "FFANY Shoes on Sale" event, in which 75,000 pairs of shoes were ordered at half the manufacturer’s suggested retail price, all in the name of cancer awareness.